GNT est le portail Hi-Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) ...

On la voit comme le nez au milieu de la figure. Il y a quelques jours, le rover Perseverance a découvert une nouvelle roche intrigante sur Mars, dans le cratère Jezero. Zébrée de blanc et de ...

L'argile (nom féminin) est une roche sédimentaire, composée pour une large part de minéraux spécifiques, silicates en général d'aluminium plus ou moins hydratés, qui présentent une structure ...

CopperEx Resources Corporation a annoncé les résultats d'un programme de creusement de tranchées de surface de 7 902 mètres ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion. The Financial Times first revealed the ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...